Menu Search
Equities

Astellas Pharma Inc

YPH:DUS

Astellas Pharma Inc

Actions
  • Price (EUR)9.58
  • Today's Change0.094 / 0.99%
  • Shares traded200.00
  • 1 Year change-12.67%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 18:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

  • Revenue in JPY (TTM)1.77tn
  • Net income in JPY54.75bn
  • Incorporated1939
  • Employees14.75k
  • Location
    Astellas Pharma Inc2-5-1, Nihombashihon-choCHUO-KU 103-8411JapanJPN
  • Phone+81 332443000
  • Websitehttps://www.astellas.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.